FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Cellectar Biosciences, Inc.
Janssen Biotech, Inc.
Innovent Biologics (Suzhou) Co. Ltd.
Allogene Therapeutics
BeOne Medicines
Celgene
GeoVax, Inc.
ADC Therapeutics S.A.
Byondis B.V.
Celgene
BeOne Medicines
Takeda
AstraZeneca
Pfizer
Immunitas Therapeutics
BeiGene
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Genmab
Takeda
Artiva Biotherapeutics, Inc.
Eli Lilly and Company
Tempus AI
Eli Lilly and Company
Ono Pharmaceutical Co. Ltd
Daiichi Sankyo
Beam Therapeutics Inc.
Taiho Oncology, Inc.
Merck Sharp & Dohme LLC
Glenmark Specialty S.A.
Celgene
MitoImmune Therapeutics
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals